Chuanxiongzin is a drug that is more commonly used in clinical practice to increase coronary flow, which can cause the patient’s coronary vessels to dilate and is used to treat ischemic cardiomyopathy. There is also the effect of dilating the peripheral blood vessels and lowering blood pressure, which can have some dilation of the pulmonary vessels, so it can improve the patient’s pulmonary blood function. There is also the effect of Chuanxiongzin on cerebral circulation, which can be used for reperfusion injury of cerebral ischemia, has a cerebral protective effect, reduces the damage of neurons and microvascular endothelium, and improves the neurological symptoms of patients. For complete transient cerebral ischemia, it has a short-term ameliorative effect and has a certain degree of promotion of brain resuscitation. It is mainly used in ischemic cerebrovascular diseases to inhibit the activation of platelets during cerebral ischemia and to adjust the impairment of cerebral microcirculation. Chuanxiongzin also has inhibitory effects on platelet aggregation and antithrombotic effects. Chuanxiongzin is widely used for ischemic cerebrovascular diseases, heart diseases, and to improve pulmonary circulation.